| 2025年年报 | 2025年中报 | 2024年年报 | 2024年中报 | |
|---|---|---|---|---|
| 营业收入(元) | ||||
| OTC(元) | 876,710,395.52 | 583,123,160.08 | 1,133,729,715.05 | 911,826,139.85 |
| 处方药(元) | 1,125,323,057.36 | 635,662,283.18 | 1,131,936,930.51 | 711,552,603.45 |
| 大健康产品(元) | 21,491,712.86 | 11,587,956.61 | 21,648,242.62 | 14,645,781.33 |
| 化工品(元) | 88,602,793.48 | - | - | - |
| 原料药(元) | 31,304,569.81 | - | - | - |
| 其他(元) | 70,133,874.08 | 31,619,478.60 | 75,635,312.14 | 35,926,796.26 |
| 营业成本(元) | ||||
| OTC(元) | 505,218,259.70 | 328,269,352.78 | 638,984,241.84 | 482,300,637.13 |
| 处方药(元) | 293,908,158.19 | 169,325,808.98 | 281,835,949.59 | 187,166,368.76 |
| 大健康产品(元) | 6,148,978.93 | - | 9,765,302.41 | - |
| 化工品(元) | 36,672,777.31 | - | - | - |
| 原料药(元) | 6,325,397.29 | - | - | - |
| 其他(元) | 31,368,915.10 | - | 36,409,017.22 | - |
| 毛利(元) | ||||
| OTC(元) | 371,492,135.82 | 254,853,807.30 | 494,745,473.21 | 429,525,502.72 |
| 处方药(元) | 831,414,899.17 | 466,336,474.20 | 850,100,980.92 | 524,386,234.69 |
| 大健康产品(元) | 15,342,733.93 | - | 11,882,940.21 | - |
| 化工品(元) | 51,930,016.17 | - | - | - |
| 原料药(元) | 24,979,172.52 | - | - | - |
| 其他(元) | 38,764,958.98 | - | 39,226,294.92 | - |
| 毛利率(%) | ||||
| OTC(%) | 42.37 | 43.70 | 43.64 | 47.11 |
| 处方药(%) | 73.88 | 73.36 | 75.10 | 73.70 |
| 大健康产品(%) | 71.39 | - | 54.89 | - |
| 化工品(%) | 58.61 | - | - | - |
| 原料药(%) | 79.79 | - | - | - |
| 其他(%) | 55.27 | - | 51.86 | - |
| 收入构成(%) | ||||
| OTC(%) | 39.61 | 46.21 | 47.98 | 54.47 |
| 处方药(%) | 50.84 | 50.37 | 47.90 | 42.51 |
| 大健康产品(%) | 0.97 | 0.92 | 0.92 | 0.87 |
| 化工品(%) | 4.00 | - | - | - |
| 原料药(%) | 1.41 | - | - | - |
| 其他(%) | 3.17 | 2.51 | 3.20 | 2.15 |
| 毛利构成(%) | ||||
| OTC(%) | 27.85 | 35.34 | 35.44 | 45.03 |
| 处方药(%) | 62.33 | 64.66 | 60.90 | 54.97 |
| 大健康产品(%) | 1.15 | 0.00 | 0.85 | 0.00 |
| 化工品(%) | 3.89 | - | - | - |
| 原料药(%) | 1.87 | - | - | - |
| 其他(%) | 2.91 | 0.00 | 2.81 | 0.00 |